Estrogen patches deliver a steady, low dose of estradiol (the body’s primary estrogen) through the skin and directly into the bloodstream. They’re most commonly prescribed to treat menopause symptoms like hot flashes and night sweats, and to help prevent bone loss after menopause. Because the hormone absorbs through the skin rather than passing through the digestive system, patches require a fraction of the dose that oral estrogen tablets need to achieve the same effect.
How Estrogen Patches Work
When you swallow an estrogen pill, it travels through your stomach and intestines into the liver before reaching the rest of your body. The liver breaks down most of the estradiol on that first pass, which means oral doses have to be much higher to compensate, and they create unnaturally high levels of estrogen byproducts in the liver. This is called the first-pass effect, and it’s the central problem that patches were designed to solve.
A transdermal patch bypasses the liver entirely. Estradiol diffuses through the skin into the small blood vessels underneath, entering general circulation at a slow, consistent rate. This produces a hormone profile that more closely resembles what the ovaries naturally released before menopause. It also means the total amount of estradiol your body needs is significantly lower than with pills.
Relief From Hot Flashes and Night Sweats
Hot flashes and night sweats, collectively called vasomotor symptoms, are the most common reason people start estrogen patches. These episodes range from a mild sensation of heat to severe sweating that stops you mid-activity. Some women experience 80 or more moderate-to-severe episodes per week at their worst.
Standard-dose estrogen therapy reduces the frequency of these episodes by roughly 80% to 83% after 12 weeks. Lower doses still offer meaningful relief, cutting episodes by about 63%, which is substantially better than the 35% to 40% improvement seen with placebo alone. The tradeoff with lower doses is timing: standard doses show significant improvement within four weeks, while lower doses take eight to 12 weeks to reach their full effect. After that 12-week mark, the gap between doses narrows considerably.
The Menopause Society considers hormone therapy the first-line treatment for bothersome vasomotor symptoms, noting that benefits typically outweigh risks for healthy women who start before age 60 or within 10 years of menopause onset.
Protection Against Bone Loss
After menopause, declining estrogen accelerates bone breakdown. Estrogen patches can slow or prevent this process. In a two-year clinical trial, women using estradiol patches at various doses showed significant increases in bone mineral density at both the lumbar spine and the femoral neck (the area of the hip most vulnerable to fracture) compared to women on placebo. Even the lowest patch dose, 0.025 mg per day, produced measurable bone preservation, and this is the dose specifically recommended for osteoporosis prevention in women who don’t need higher doses for symptom relief.
Lower Blood Clot Risk Than Pills
One of the most important advantages of patches over oral estrogen is their effect on blood clot risk. A major multicenter study found that oral estrogen users had a 4.2 times higher risk of venous thromboembolism (blood clots in the legs or lungs) compared to nonusers. Transdermal estrogen users, by contrast, had no increased risk at all, with an odds ratio of 0.9, essentially the same as women not taking any estrogen.
The explanation ties back to the first-pass effect. When high concentrations of estrogen hit the liver directly, they trigger production of clotting factors and inflammatory proteins. Patches skip that step, so they have little to no effect on these prothrombotic substances. The American College of Obstetricians and Gynecologists has highlighted this distinction, noting that transdermal estrogen may even have beneficial effects on certain inflammatory markers like C-reactive protein.
Available Doses and Patch Schedules
Estrogen patches come in five standard strengths: 0.025, 0.0375, 0.05, 0.075, and 0.1 mg per day. These numbers refer to how much estradiol the patch releases over 24 hours, not the total amount of hormone in the patch itself. The typical starting dose for hot flashes and vaginal dryness is 0.0375 mg per day. For osteoporosis prevention alone, the starting dose is lower at 0.025 mg per day.
Depending on the brand, you’ll change your patch either once or twice a week. Twice-weekly patches are more common. You apply the patch to clean, dry skin on your hip, lower abdomen, or buttock, rotating to a different spot each time to reduce skin irritation. Avoid the waistline where clothing rubs, and don’t apply to the breasts.
Why Progestin Is Often Prescribed Alongside
Estrogen, whether delivered by patch, pill, or any other method, causes the uterine lining to thicken over time. Without something to counteract this effect, the ongoing buildup raises the risk of endometrial cancer. If you still have your uterus, your prescriber will add a progestin (a synthetic form of progesterone) to your regimen. The progestin periodically thins the uterine lining, keeping that risk in check. Women who have had a hysterectomy can use estrogen patches alone.
Side Effects to Expect
Skin reactions are the most common complaint. Roughly 20% of patch users report some form of skin irritation at the application site, ranging from mild redness and itching to more noticeable contact dermatitis. Rotating the patch location with each change helps, and most reactions resolve quickly once the patch is removed. Switching to a different patch brand sometimes solves persistent irritation, since the adhesive formulation varies between products.
Systemic side effects, meaning those that affect the whole body rather than just the skin, are similar to other forms of estrogen therapy. Breast tenderness, headaches, and nausea are the most frequently reported, though nausea tends to be less common with patches than with oral estrogen since the hormone isn’t passing through the stomach. These side effects are often dose-related and may improve after the first few months or with a dose reduction.